Updated:
Bioshore Capital Partners
Bioshore invests in world-leading medical technologies to fill Australia's gap in knowledgeable and patient risk capital for medtech. Its objective is to...
Overview
Bioshore invests in world-leading medical technologies to fill Australia's gap in knowledgeable and patient risk capital for medtech. Its objective is to commercialise leading innovations to improve patient outcomes and lower the global cost of delivering healthcare. The firm is the investment manager of Bioshore Ventures Fund 1, an Early Stage Venture Capital Limited Partnership.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
Oceania
Country
Australia
City
Sydney
Corporate office
Sydney, Australia
Principals
Andrew Fox-Smith
General Partner
Jeff Reid
General Partner
David Bottomley
General Partner
Robert Cusack
Investment Committee
Dr Jonothon Brock
Investment Committee
Anne O'Neill
Advisory Board
Andrew T Rock
Advisory Board
Will Knox
Advisory Board
Sector focus
Frequently asked questions
How does Bioshore source its investment opportunities?
Bioshore relies on deep scientific and clinical networks within Australia's research community — universities, medical research institutes, and hospital systems — rather than broad marketing or intermediary channels. The firm's deliberately low public profile supports a relationship-driven sourcing model.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: